Meropenem - Revision history

Danbot: Remove disease-specific entries now covered by AntibioticDose (1 sections)

2026-03-20T11:08:07Z

Remove disease-specific entries now covered by AntibioticDose (1 sections)

2026-03-20T02:38:30Z

Restore original dosing content alongside dynamic SMW tables

← Older revision		Revision as of 02:38, 20 March 2026
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
			===General===
			*1.5-6g IV daily, divided q8 hours
			*First Dose: 0.5-2g IV x 1

			===[[Meningitis]]===
			*2g IV every 8 hours.


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Meropenem]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Meropenem]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			===General (≥3 Months)===
			*30-120mg/kg/day IV divided q8 hours
			*First Dose: 10-40mg/kg IV x 1
			*Max: 6 g/day


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Meropenem]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Meropenem]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

2026-03-20T01:52:21Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Older revision		Revision as of 01:52, 20 March 2026
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	===~~General~~===		===Indications by Disease===
	*1.5-6g IV daily, divided q8 hours		{{#ask: [[Has DrugName::Meropenem]] [[Has Population::Adult]]
	*First Dose~~: 0.5-2g IV x 1~~		\|?Treats disease=Disease
			\|?Has Dose=Dose
	===~~[[Meningitis]]=~~==		\|?Has Context=Context
	*2g IV every 8 hours.		\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Pediatric Dosing==		==Pediatric Dosing==
	===~~General (≥3 Months)~~===		===Indications by Disease===
	*30-120mg/kg/day IV divided q8 hours		{{#ask: [[Has DrugName::Meropenem]] [[Has Population::Pediatric]]
	*First Dose~~: 10~~-~~40mg/kg IV x 1~~		\|?Treats disease=Disease
	*Max: 6 g/day		\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

2025-08-03T04:31:56Z

← Older revision		Revision as of 04:31, 3 August 2025
Line 128:		Line 128:
	\| \|\|[[Klebsiella]] sp\|\|'''S'''		\| \|\|[[Klebsiella]] sp\|\|'''S'''
	\|-		\|-
	\| \|\|E. coli/Klebsiella ESBL+\|\|'''S'''		\| \|\|E. coli/Klebsiella ESBL+\|\|'''[[Has ESBL::S]]'''
	\|-		\|-
	\| \|\|E coli/Klebsiella KPC+\|\|R		\| \|\|E coli/Klebsiella KPC+\|\|R

2025-07-30T15:45:11Z

← Older revision		Revision as of 15:45, 30 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: [[~~Is DrugClass::~~Carbapenems]]		*Type: [[Carbapenems]]
	*Dosage Forms: IV		*Dosage Forms: IV
	*Common Trade Names: Merrem		*Common Trade Names: Merrem
Line 9:		Line 9:
	*First Dose: 0.5-2g IV x 1		*First Dose: 0.5-2g IV x 1

	==Meningitis ~~Dosing~~==		===[[Meningitis]]===
	*2g IV every 8 hours.		*2g IV every 8 hours.

Line 128:		Line 128:
	\| \|\|[[Klebsiella]] sp\|\|'''S'''		\| \|\|[[Klebsiella]] sp\|\|'''S'''
	\|-		\|-
	\| \|\|E. coli/Klebsiella ESBL+\|\|'''~~[[Has ESBL::~~S]]'''		\| \|\|E. coli/Klebsiella ESBL+\|\|'''S'''
	\|-		\|-
	\| \|\|E coli/Klebsiella KPC+\|\|R		\| \|\|E coli/Klebsiella KPC+\|\|R
Line 162:		Line 162:
	\| \|\|[[Acinetobacter sp.]]\|\|I		\| \|\|[[Acinetobacter sp.]]\|\|I
	\|-		\|-
	\| \|\|[[Pseudomonas aeruginosa]]\|\|'''~~[[Has Antipseudomonal::~~S]]'''		\| \|\|[[Pseudomonas aeruginosa]]\|\|'''S'''
	\|-		\|-
	\| \|\|[[Burkholderia cepacia]]\|\|'''S'''		\| \|\|[[Burkholderia cepacia]]\|\|'''S'''

2025-07-19T19:23:51Z

← Older revision		Revision as of 19:23, 19 July 2025
Line 128:		Line 128:
	\| \|\|[[Klebsiella]] sp\|\|'''S'''		\| \|\|[[Klebsiella]] sp\|\|'''S'''
	\|-		\|-
	\| \|\|E. coli/Klebsiella ESBL+\|\|'''S'''		\| \|\|E. coli/Klebsiella ESBL+\|\|'''[[Has ESBL::S]]'''
	\|-		\|-
	\| \|\|E coli/Klebsiella KPC+\|\|R		\| \|\|E coli/Klebsiella KPC+\|\|R

2025-07-18T18:22:42Z

← Older revision		Revision as of 18:22, 18 July 2025
Line 162:		Line 162:
	\| \|\|[[Acinetobacter sp.]]\|\|I		\| \|\|[[Acinetobacter sp.]]\|\|I
	\|-		\|-
	\| \|\|[[Pseudomonas aeruginosa]]\|\|'''S'''		\| \|\|[[Pseudomonas aeruginosa]]\|\|'''[[Has Antipseudomonal::S]]'''
	\|-		\|-
	\| \|\|[[Burkholderia cepacia]]\|\|'''S'''		\| \|\|[[Burkholderia cepacia]]\|\|'''S'''

2025-07-18T17:12:31Z

← Older revision		Revision as of 17:12, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: [[Carbapenems]]		*Type: [[Is DrugClass::Carbapenems]]
	*Dosage Forms: IV		*Dosage Forms: IV
	*Common Trade Names: Merrem		*Common Trade Names: Merrem

2025-07-09T20:56:06Z

General

2024-11-06T16:09:38Z

← Older revision		Revision as of 16:09, 6 November 2024
Line 3:		Line 3:
	*Dosage Forms: IV		*Dosage Forms: IV
	*Common Trade Names: Merrem		*Common Trade Names: Merrem
	*Has activity against ESBL organisms

	==Adult Dosing==		==Adult Dosing==
Line 78:		Line 77:
	*Excretion: Urine, active secretion (70% unchanged)		*Excretion: Urine, active secretion (70% unchanged)
	*Mechanism of Action: Inhibits cell wall synthesis		*Mechanism of Action: Inhibits cell wall synthesis

			==Mechanism of Action==

			==Comments==
			*Has activity against ESBL organisms

	==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==		==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==